The Rockville biotech says two versions of its ADHD drug could serve a potential $7 billion market.
{iframe}http://www.bizjournals.com/washington/news/2016/10/11/a-supernus-drug-candidate-with-a-2-5b-market-just.html?ana=e_mc_prem&s=newsletter&ed=2016-10-12&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1476448275&j=76097861{/iframe}